These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5477430)

  • 1. Some central effects of diethyldithiocarbamate administered intraventricularly in rats.
    Kleinrok Z; Zebrowska I; Wielosz M
    Neuropharmacology; 1970 Sep; 9(5):451-5. PubMed ID: 5477430
    [No Abstract]   [Full Text] [Related]  

  • 2. The central action of intraventricularly (ivc) administered propranolol and phentolamine in rat.
    Kleinrok Z; Ksiazek A; Przesmycki K; Kolasa K
    Pol J Pharmacol Pharm; 1975; 27(4):405-12. PubMed ID: 1166021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological effects of ouabain administered intracerebrally to conscious mice.
    Doggett NS; Spencer PS; Turner TA
    Br J Pharmacol; 1970 Sep; 40(1):138P-139P. PubMed ID: 5487004
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioural effects of yohimbine administered intraventricularly in the rat.
    Zebrowska-Lupina I; Kleinrok Z
    Psychopharmacologia; 1973; 33(3):267-75. PubMed ID: 4785908
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of diethyldithiocarbamate on the toxicity of amphetamine in aggregated mice.
    Przegalinski E; Kleinrok Z
    Psychopharmacologia; 1970; 16(5):409-18. PubMed ID: 5435877
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence that in rats 1-benzyl- -methoxy-3-trifluoromethylphenethylamine (SK& F 1-39728) dissociates anorexia from central stimulation and actions on brain monoamine stores.
    Groppetti A; Misher A; Naimzada M; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1972 Sep; 182(3):464-73. PubMed ID: 5055405
    [No Abstract]   [Full Text] [Related]  

  • 7. A cntral site for the hypothermic effects of (+)-amphetamine sulphate and p-hydroxyamphetamine hydrobromide in mice.
    McCullough DO; Milberg JN; Robinson SM
    Br J Pharmacol; 1970 Oct; 40(2):219-26. PubMed ID: 5492894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice.
    Moore KE
    Biochem Pharmacol; 1969 Jul; 18(7):1627-34. PubMed ID: 5806105
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of centrally administered ouabain and their modification by other drugs.
    Doggett NS; Spencer PS
    Br J Pharmacol; 1971 Jun; 42(2):242-53. PubMed ID: 4326323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central action of phentolamine administered intraventricularly in the rat.
    Kleinrok Z; Zebrowska-Lupina I
    Psychopharmacologia; 1971; 20(4):348-54. PubMed ID: 5109250
    [No Abstract]   [Full Text] [Related]  

  • 11. Central effects of 6-hydroxydopamine on the body temperature of the rat.
    Simmonds MA; Uretsky NJ
    Br J Pharmacol; 1970 Dec; 40(4):630-8. PubMed ID: 5495172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine.
    Uretsky NJ; Schoenfeld RI
    Nat New Biol; 1971 Dec; 234(48):157-9. PubMed ID: 5289320
    [No Abstract]   [Full Text] [Related]  

  • 13. On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.
    Modigh K; Svensson TH
    Br J Pharmacol; 1972 Sep; 46(1):32-45. PubMed ID: 4263796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system effects of fenfluramine hydrochloride.
    Ziance RJ; Sipes IG; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1972 Jan; 180(1):110-7. PubMed ID: 5062254
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of intraventricularly administered noradrenaline and dopamine on the body temperature of the rat.
    Przewlocka B; Kaluza J
    Pol J Pharmacol Pharm; 1973; 25(4):345-55. PubMed ID: 4774243
    [No Abstract]   [Full Text] [Related]  

  • 16. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats. I. Possible role of dopaminergic nervous system.
    Fujimori K; Iwamoto T
    Neuropharmacology; 1974 Apr; 13(4):245-54. PubMed ID: 4853135
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations on the central pharmacological actions of noradnamine, a proposed depressive catabolite of noradrenaline.
    Chambers DM; Redfern PH; Roberts DJ
    Int J Neuropharmacol; 1967 Sep; 6(5):417-22. PubMed ID: 6055321
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.